Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Unspecified bisphosphonate/zoledronic acid

Medication related osteonecrosis of the jaw

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ekpe V, et al. A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis. Journal of the Endocrine Society 7 (Suppl. 1): A219-A220 abstr. THU442, Oct 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.403 [abstract] Ekpe V, et al. A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis. Journal of the Endocrine Society 7 (Suppl. 1): A219-A220 abstr. THU442, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvad114.​403 [abstract]
Metadaten
Titel
Unspecified bisphosphonate/zoledronic acid
Medication related osteonecrosis of the jaw
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51286-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Mifepristone

Case report

Metformin

Case report

Lidocaine

Case report

Nivolumab

Case report

Immunotherapies